# TeLIPro Health Program - Active With Diabetes

Study · id `cardio:ct-nct03675919` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03675919](<https://clinicaltrials.gov/study/NCT03675919>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03675919

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1163 participants.

## Technical summary

Registry record NCT03675919. Randomized; single masking; primary purpose supportive care. Start 2018-09-15 (actual); primary completion 2021-09-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 1163 participants (enrolled count; ClinicalTrials.gov record NCT03675919, source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)
- Started: 2018-09-15 (actual) (ClinicalTrials.gov record NCT03675919, source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)
- Primary completion: 2021-09-21 (actual) (ClinicalTrials.gov record NCT03675919, source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)
- Completion: 2022-09-30 (actual) (ClinicalTrials.gov record NCT03675919, source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT03675919, source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03675919-2023-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: TeLIPro Health Program - Active With Diabetes
- Acronym: TeLIPro
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Scale
- Intervention (Device): Step counter
- Intervention (Device): Blood glucose meter with test stripes
- Intervention (Other): Access to the online portal
- Intervention (Other): Telemedical coaching
- Lead sponsor: West German Center of Diabetes and Health
- Lead sponsor class: OTHER
- Collaborator: AOK Rheinland/Hamburg
- Collaborator class: INDUSTRY
- Collaborator: German Institute for Telemedicine and Health Promotion
- Collaborator class: OTHER
- Collaborator: German Diabetes Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: d52b90934ece12d30cfe4989df333c76b69e46a4a54471036144f30ee6433c89
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
